跳至主要内容
临床试验/JPRN-UMIN000050152
JPRN-UMIN000050152
已完成
未知

Clinical study to confirm anti-sarcopenia effect of test food. - Clinical study to confirm anti-sarcopenia effect of test food.

EP Mediate Co., Ltd0 个研究点目标入组 50 人2023年1月30日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
EP Mediate Co., Ltd
入组人数
50
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年1月30日
结束日期
2023年8月10日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 未提供

排除标准

  • Subjects (1\) who have or have a history of any disease that may affect the evaluation of the study (2\) who have difficulty in daily activities or walking due to severe pain, or who are unable to perform exercise training (3\) diagnosed with sarcopenia (4\) who have a possibility of recurrence of locomotory disease due to exercise training (5\) who regularly use health foods that may affect the evaluation of the study (6\) who regularly use pharmaceuticals (7\) who exercise regularly (8\) who exercise excessively (9\) with a history of locomotory disease within 1 year before the screening examination (10\) who use canes or supporters (11\) who periodically conduct actions that may affect the evaluation of effectiveness (12\) who are under treatment of diseases on the joints (13\) who have or have a history of severe diseases (14\) who are under treatment or have a history of mental diseases (15\) who have unsteady lifestyle or who work manual labor (16\) who drink a lot (17\) who have possibilities for emerging allergy onset related to the study (18\) who are judged as unsuitable for the study based on the results of screening examination (19\) who have participated in other clinical study within a month before the screening test or who intend to participate in the study period (20\) who are in a pregnancy or lactation period in the study period (21\) who are judged as unsuitable due to lifestyle questionnaire (22\) who cannot carry out the test as instructed (23\) who are judged as unsuitable for the study by investigator for other reasons

结局指标

主要结局

未指定

相似试验